Janus Henderson Group PLC Purchases 17,641 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Janus Henderson Group PLC increased its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 31.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 73,005 shares of the company's stock after acquiring an additional 17,641 shares during the quarter. Janus Henderson Group PLC owned about 0.40% of Addus HomeCare worth $9,150,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ADUS. Dimensional Fund Advisors LP raised its position in shares of Addus HomeCare by 1.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 692,713 shares of the company's stock valued at $86,833,000 after purchasing an additional 10,434 shares during the period. Capital Research Global Investors purchased a new position in Addus HomeCare in the 4th quarter valued at approximately $51,149,000. TimesSquare Capital Management LLC raised its holdings in Addus HomeCare by 28.5% during the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock valued at $44,593,000 after acquiring an additional 78,835 shares during the period. Invesco Ltd. raised its holdings in Addus HomeCare by 6.5% during the 4th quarter. Invesco Ltd. now owns 346,120 shares of the company's stock valued at $43,386,000 after acquiring an additional 21,266 shares during the period. Finally, Northern Trust Corp lifted its position in shares of Addus HomeCare by 3.3% during the fourth quarter. Northern Trust Corp now owns 285,872 shares of the company's stock worth $35,834,000 after acquiring an additional 9,122 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS traded up $1.42 during midday trading on Tuesday, hitting $112.51. 184,788 shares of the company's stock traded hands, compared to its average volume of 166,057. The firm has a fifty day moving average of $101.10 and a 200 day moving average of $113.55. Addus HomeCare Co. has a 1 year low of $88.96 and a 1 year high of $136.72. The stock has a market capitalization of $2.07 billion, a price-to-earnings ratio of 25.75, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.09. The business had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company's quarterly revenue was up 20.3% on a year-over-year basis. During the same period last year, the firm earned $1.21 earnings per share. On average, equities analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms recently issued reports on ADUS. Stephens reiterated an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. Oppenheimer lifted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. JMP Securities restated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a report on Tuesday, April 22nd. Macquarie upped their price target on Addus HomeCare from $129.00 to $133.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th. Finally, StockNews.com downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $142.57.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.